A decision to approve new medicines to treat Duchenne muscular dystrophy and a rare life-threatening blood disease for use in ...

The Press and Public Relations Coordination of the National Police of Haiti (PNH) announces that this Friday, January 10, 2025 at 9:00 a.m., the graduation ceremony of the 34th promotion of the PNH ...

Prime Minister Alix Didier Fils-Aimé participated in the graduation ceremony of the 34th promotion "Vertières" of the Haitian National Police (PNH) organized at the National Police School on the ...

Roche's PiaSky has been approved by the European Commission, becoming the first therapy for rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH) that can be given by monthly subcutaneous ...

This therapy is the first to activate specific components of the ... Study Traces Ebola's Route to the Skin Surface Jan. 1, 2025 — Researchers have traced a cellular route Ebola virus (EBOV ...

The mainstay of therapy for the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) is Alexion's infusion therapy Soliris, but Novartis' iptacopan could provide an oral option after ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Dermatitis refers to skin inflammation. Types include atopic dermatitis (eczema), contact dermatitis, seborrheic dermatitis, and dishydrotic dermatitis. Symptoms may include dry skin, itchiness ...

In almost a decade as a beauty writer, I’ve spent a not-insignificant amount of time testing lotions on my uncomfortably dry skin. I’ve sourced recommendations from dermatologists, shower ...

A demand for nurse-midwifery care emerged in the immediate aftermath of World War II. Initially, workforce needs were focused on provision of care to poor and working class women, but by the late ...

Overall tolerability and safety were assessed, and skin sensory testing was conducted to determine whether local anesthetic activity was produced. The mean maximum plasma lidocaine concentrations ...

The comment period for the Federal Register Notice, “Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for ...